Previous close | 254.85 |
Open | 248.66 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1100 |
Day's range | 244.42 - 259.86 |
52-week range | 164.47 - 279.02 |
Volume | |
Avg. volume | 1,255,445 |
Market cap | 72.028B |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | 13.30 |
EPS (TTM) | 19.15 |
Earnings date | 20 Apr 2023 - 24 Apr 2023 |
Forward dividend & yield | 2.40 (0.94%) |
Ex-dividend date | 16 Mar 2023 |
1y target est | 265.55 |
HCA Healthcare ( NYSE:HCA ) Full Year 2022 Results Key Financial Results Revenue: US$60.2b (up 2.5% from FY 2021). Net...
At this time, for opening remarks and introductions, I would like to turn the call over to vice president of investor relations, Mr. Frank Morgan. With me this morning is our CEO, Sam Hazen; and CFO, Bill Rutherford.
HCA Healthcare's (HCA) fourth-quarter results suffer a blow from added expenses incurred due to Hurricane Ian. Increased patient admissions partly offset the downside.